# Expensify, Inc.: financial statements, quarterly EXFY · Nasdaq · CIK 1476840 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/exfy.md) · [Financials](/companies/exfy/financials.md) · [Filings](/companies/exfy/filings.md) · [Insiders](/companies/exfy/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/exfy/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [36.5](/filings/0001476840-24-000215.md) | [35.2 d](/filings/0001476840-25-000018.md) | [33.5](/filings/0001476840-25-000070.md) | [33.3](/filings/0001476840-25-000115.md) | [35.4](/filings/0001476840-25-000137.md) | [37.0 d](/filings/0001476840-26-000009.md) | [36.1](/filings/0001476840-26-000032.md) | [35.8](/filings/0001476840-26-000072.md) | [35.1](/filings/0001476840-25-000137.md) | [35.2 d](/filings/0001476840-26-000009.md) | [34.0](/filings/0001476840-26-000032.md) | [33.9](/filings/0001476840-26-000072.md) | | Cost of revenue | $m | [17.7](/filings/0001476840-24-000215.md) | [16.5 d](/filings/0001476840-25-000018.md) | [14.6](/filings/0001476840-25-000070.md) | [14.4](/filings/0001476840-25-000115.md) | [17.1](/filings/0001476840-25-000137.md) | [18.1 d](/filings/0001476840-26-000009.md) | [17.8](/filings/0001476840-26-000032.md) | [17.2](/filings/0001476840-26-000072.md) | [17.7](/filings/0001476840-25-000137.md) | [17.9 d](/filings/0001476840-26-000009.md) | [17.8](/filings/0001476840-26-000032.md) | [17.5](/filings/0001476840-26-000072.md) | | Gross profit | $m | [18.8](/filings/0001476840-24-000215.md) | [18.7 d](/filings/0001476840-25-000018.md) | [19.0](/filings/0001476840-25-000070.md) | [18.9](/filings/0001476840-25-000115.md) | [18.3](/filings/0001476840-25-000137.md) | [18.9 d](/filings/0001476840-26-000009.md) | [18.2](/filings/0001476840-26-000032.md) | [18.6](/filings/0001476840-26-000072.md) | [17.4](/filings/0001476840-25-000137.md) | [17.3 d](/filings/0001476840-26-000009.md) | [16.2](/filings/0001476840-26-000032.md) | [16.3](/filings/0001476840-26-000072.md) | | Research and development | $m | [6.6](/filings/0001476840-24-000215.md) | [6.2 d](/filings/0001476840-25-000018.md) | [5.9](/filings/0001476840-25-000070.md) | [6.4](/filings/0001476840-25-000115.md) | [5.6](/filings/0001476840-25-000137.md) | [6.7 d](/filings/0001476840-26-000009.md) | [5.4](/filings/0001476840-26-000032.md) | [5.2](/filings/0001476840-26-000072.md) | [4.9](/filings/0001476840-25-000137.md) | [5.3 d](/filings/0001476840-26-000009.md) | [5.3](/filings/0001476840-26-000032.md) | [5.0](/filings/0001476840-26-000072.md) | | Operating income | $m | [(14.9)](/filings/0001476840-24-000215.md) | [(6.0) d](/filings/0001476840-25-000018.md) | [(1.8)](/filings/0001476840-25-000070.md) | [0.2](/filings/0001476840-25-000115.md) | [0.3](/filings/0001476840-25-000137.md) | [0.5 d](/filings/0001476840-26-000009.md) | [(1.5)](/filings/0001476840-26-000032.md) | [(10.3)](/filings/0001476840-26-000072.md) | [(2.3)](/filings/0001476840-25-000137.md) | [(3.9) d](/filings/0001476840-26-000009.md) | [(2.0)](/filings/0001476840-26-000032.md) | [(2.9)](/filings/0001476840-26-000072.md) | | Interest expense | $m | not reported | not reported | not reported | [0.3](/filings/0001476840-24-000156.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(0.3)](/filings/0001476840-24-000215.md) | [1.0 d](/filings/0001476840-25-000018.md) | [1.0](/filings/0001476840-25-000070.md) | [2.7](/filings/0001476840-25-000115.md) | [2.7](/filings/0001476840-25-000137.md) | [1.2 d](/filings/0001476840-26-000009.md) | [2.0](/filings/0001476840-26-000032.md) | [(0.7)](/filings/0001476840-26-000072.md) | [0.2](/filings/0001476840-25-000137.md) | [3.6 d](/filings/0001476840-26-000009.md) | [0.5](/filings/0001476840-26-000032.md) | [1.1](/filings/0001476840-26-000072.md) | | Net income | $m | [(17.0)](/filings/0001476840-24-000215.md) | [(7.2) d](/filings/0001476840-25-000018.md) | [(3.8)](/filings/0001476840-25-000070.md) | [(2.8)](/filings/0001476840-25-000115.md) | [(2.2)](/filings/0001476840-25-000137.md) | [(1.3) d](/filings/0001476840-26-000009.md) | [(3.2)](/filings/0001476840-26-000032.md) | [(8.8)](/filings/0001476840-26-000072.md) | [(2.3)](/filings/0001476840-25-000137.md) | [(7.1) d](/filings/0001476840-26-000009.md) | [(2.3)](/filings/0001476840-26-000032.md) | [(3.9)](/filings/0001476840-26-000072.md) | | Diluted EPS | $ per share | [(0.21)](/filings/0001476840-24-000215.md) | not reported | [(0.04)](/filings/0001476840-25-000070.md) | [(0.03)](/filings/0001476840-25-000115.md) | [(0.02)](/filings/0001476840-25-000137.md) | not reported | [(0.03)](/filings/0001476840-26-000032.md) | [(0.10)](/filings/0001476840-26-000072.md) | [(0.03)](/filings/0001476840-25-000137.md) | not reported | [(0.02)](/filings/0001476840-26-000032.md) | [(0.04)](/filings/0001476840-26-000072.md) | | Basic EPS | $ per share | [(0.21)](/filings/0001476840-24-000215.md) | not reported | [(0.04)](/filings/0001476840-25-000070.md) | [(0.03)](/filings/0001476840-25-000115.md) | [(0.02)](/filings/0001476840-25-000137.md) | not reported | [(0.03)](/filings/0001476840-26-000032.md) | [(0.10)](/filings/0001476840-26-000072.md) | [(0.03)](/filings/0001476840-25-000137.md) | not reported | [(0.02)](/filings/0001476840-26-000032.md) | [(0.04)](/filings/0001476840-26-000072.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [89.1](/filings/0001476840-24-000215.md) | [47.5](/filings/0001476840-25-000018.md) | [49.3](/filings/0001476840-25-000070.md) | [53.2](/filings/0001476840-25-000115.md) | [39.2](/filings/0001476840-25-000137.md) | [48.8](/filings/0001476840-26-000009.md) | [59.6](/filings/0001476840-26-000032.md) | [60.5](/filings/0001476840-26-000072.md) | [61.5](/filings/0001476840-25-000137.md) | [63.1](/filings/0001476840-26-000072.md) | [66.5](/filings/0001476840-26-000032.md) | [65.8](/filings/0001476840-26-000072.md) | | Current assets | $m | [180](/filings/0001476840-23-000187.md) | [137](/filings/0001476840-25-000018.md) | [143](/filings/0001476840-24-000069.md) | [156](/filings/0001476840-24-000156.md) | [139](/filings/0001476840-24-000215.md) | [137](/filings/0001476840-26-000009.md) | [154](/filings/0001476840-25-000070.md) | [152](/filings/0001476840-25-000115.md) | [153](/filings/0001476840-25-000137.md) | [153](/filings/0001476840-26-000072.md) | [158](/filings/0001476840-26-000032.md) | [154](/filings/0001476840-26-000072.md) | | Total assets | $m | [212](/filings/0001476840-23-000187.md) | [177](/filings/0001476840-25-000018.md) | [185](/filings/0001476840-24-000069.md) | [193](/filings/0001476840-24-000156.md) | [176](/filings/0001476840-24-000215.md) | [174](/filings/0001476840-26-000009.md) | [189](/filings/0001476840-25-000070.md) | [187](/filings/0001476840-25-000115.md) | [187](/filings/0001476840-25-000137.md) | [186](/filings/0001476840-26-000072.md) | [191](/filings/0001476840-26-000032.md) | [185](/filings/0001476840-26-000072.md) | | Current liabilities | $m | [73.8](/filings/0001476840-23-000187.md) | [67.9](/filings/0001476840-25-000018.md) | [70.3](/filings/0001476840-24-000069.md) | [70.8](/filings/0001476840-24-000156.md) | [48.3](/filings/0001476840-24-000215.md) | [38.0](/filings/0001476840-26-000009.md) | [47.3](/filings/0001476840-25-000070.md) | [48.4](/filings/0001476840-25-000115.md) | [44.4](/filings/0001476840-25-000137.md) | [46.4](/filings/0001476840-26-000072.md) | [45.3](/filings/0001476840-26-000032.md) | [44.1](/filings/0001476840-26-000072.md) | | Total liabilities | $m | [117](/filings/0001476840-23-000187.md) | [76.0](/filings/0001476840-25-000018.md) | [78.3](/filings/0001476840-24-000069.md) | [78.9](/filings/0001476840-24-000156.md) | [56.3](/filings/0001476840-24-000215.md) | [45.4](/filings/0001476840-26-000009.md) | [54.6](/filings/0001476840-25-000070.md) | [55.3](/filings/0001476840-25-000115.md) | [51.2](/filings/0001476840-25-000137.md) | [53.2](/filings/0001476840-26-000072.md) | [52.1](/filings/0001476840-26-000032.md) | [50.8](/filings/0001476840-26-000072.md) | | Long-term debt | $m | [35.6](/filings/0001476840-23-000187.md) | [0.0](/filings/0001476840-24-000016.md) | [0.0](/filings/0001476840-24-000069.md) | [0.0](/filings/0001476840-24-000156.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | [8.1](/filings/0001476840-23-000187.md) | [7.7](/filings/0001476840-25-000018.md) | [7.6](/filings/0001476840-24-000069.md) | [7.6](/filings/0001476840-24-000156.md) | [0.0](/filings/0001476840-24-000215.md) | [0.0](/filings/0001476840-25-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [95.1](/filings/0001476840-24-000215.md) | [101](/filings/0001476840-26-000009.md) | [107](/filings/0001476840-25-000115.md) | [114](/filings/0001476840-25-000137.md) | [120](/filings/0001476840-25-000137.md) | [128](/filings/0001476840-26-000072.md) | [135](/filings/0001476840-26-000072.md) | [132](/filings/0001476840-26-000072.md) | [136](/filings/0001476840-25-000137.md) | [133](/filings/0001476840-26-000072.md) | [139](/filings/0001476840-26-000072.md) | [135](/filings/0001476840-26-000072.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(5,106) d](/filings/0001476840-24-000215.md) | [(543) d](/filings/0001476840-25-000018.md) | [3,471](/filings/0001476840-25-000070.md) | [9,317 d](/filings/0001476840-25-000115.md) | [3,687 d](/filings/0001476840-25-000137.md) | [7,402 d](/filings/0001476840-26-000009.md) | [7,856](/filings/0001476840-26-000032.md) | [8,184 d](/filings/0001476840-26-000072.md) | [1,847 d](/filings/0001476840-25-000137.md) | [2,202 d](/filings/0001476840-26-000009.md) | [118](/filings/0001476840-26-000032.md) | [8,433 d](/filings/0001476840-26-000072.md) | | Capital expenditure | $k | [624 d](/filings/0001476840-24-000215.md) | [281 d](/filings/0001476840-25-000018.md) | [0.0](/filings/0001476840-24-000069.md) | [0.0 d](/filings/0001476840-25-000115.md) | [0.0 d](/filings/0001476840-25-000137.md) | [0.0 d](/filings/0001476840-26-000009.md) | not reported | not reported | [0.0 d](/filings/0001476840-25-000137.md) | [0.0 d](/filings/0001476840-26-000009.md) | not reported | not reported | | Share repurchases | $k | [0.0 d](/filings/0001476840-24-000215.md) | [0.0 d](/filings/0001476840-25-000018.md) | not reported | not reported | [1,510 d](/filings/0001476840-25-000137.md) | [0.0 d](/filings/0001476840-26-000009.md) | not reported | not reported | [3,031 d](/filings/0001476840-25-000137.md) | [3,038 d](/filings/0001476840-26-000009.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [80.9](/filings/0001476840-23-000187.md) | [81.8](/filings/0001476840-24-000069.md) | [82.0](/filings/0001476840-24-000156.md) | [82.5](/filings/0001476840-24-000215.md) | [85.1](/filings/0001476840-25-000070.md) | [86.6](/filings/0001476840-25-000115.md) | [88.2](/filings/0001476840-25-000137.md) | [91.5](/filings/0001476840-26-000032.md) | [92.3](/filings/0001476840-26-000072.md) | [92.6](/filings/0001476840-25-000137.md) | [93.7](/filings/0001476840-26-000032.md) | [95.4](/filings/0001476840-26-000072.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.